AKA. O. Kipot

A. O. Kipot

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. O. Kipot has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Planned Versus Standby V‐A ECMO Strategy During High‐Risk PCI: A Retrospective Cohort Study

    by Mykhailo Todurov, Borys Todurov, Yulia Zybaha, Artem Kipot, Stepan Maruniak

    Background: The role of mechanical circulatory support (MCS) in high‐risk percutaneous coronary intervention (HR‐PCI) remains controversial, and the optimal timing of its initiation is not well defined. Veno‐arterial extracorporeal membrane oxygenation (V‐A ECMO) provides full hemodynamic support; however, comparative data on planned versus standby strategies are limited. Aim: To compare clinical outcomes of planned versus standby V‐A ECMO support in patients undergoing elective HR‐PCI, with a focus on the impact of timing of ECMO initiation. Methods: This single‐center retrospective observational study included 74 consecutive patients who underwent high‐risk PCI between 2019 and 2025 and were managed according to a preprocedurally determined V‐A ECMO strategy. Before PCI, the multidisciplinary Heart Team selected either a planned strategy ( n = 43), in which V‐A ECMO was initiated before PCI, or a standby strategy ( n = 31), in which ECMO equipment and vascular access were prepared in advance, but ECMO was initiated only in response to predefined intraprocedural hemodynamic deterioration. The primary endpoint was in‐hospital major adverse cardiac and cerebrovascular events (MACCE), defined as a composite of death, myocardial infarction, stroke, and repeat revascularization. Results: No statistically significant differences were observed in the measured baseline variables. ECMO support during PCI was required in 19/32 (61.3%) of patients in the standby‐strategy group. The incidence of in‐hospital MACCE was significantly higher in the standby‐strategy group compared with the planned‐strategy group (48.4% vs. 14.0%, p = 0.002). The standby‐strategy group also had longer ICU stay (8 [5–12] vs. 6 [4–9] days, p = 0.03) and hospital stay (15 [11–20] vs. 12 [9–16] days, p = 0.02), as well as higher vasoactive‐inotropic scores ( p = 0.033). In multivariable analysis, the standby strategy was associated with higher odds of in‐hospital MACCE after adjustment (adjusted OR, 4.20; 95% CI, 1.35–13.10; p = 0.013). Conclusions: In this single‐center retrospective cohort of patients undergoing elective HR‐PCI, a planned V‐A ECMO strategy was associated with a lower incidence of in‐hospital MACCE than a standby strategy. Given the nonrandomized treatment allocation, inclusion of standby patients who did not ultimately require ECMO, and limited number of events, these findings are hypothesis‐generating and do not establish a causal benefit of planned ECMO or harm from rescue initiation.


  • Open Access

    High-risk thrombosis of a mechanical aortic valve: successful thrombolysis as a bridge or an alternative to surgery

    by A.O. Kipot, L.R. Stetsyuk, M.B. Todurov, B.M. Todurov

    Thrombosis of a mechanical aortic valve prosthesis is a rare, yet potentially life-threatening complication that demands urgent recognition, rapid diagnostic evaluation, and immediate therapeutic intervention. We describe a detailed clinical case of a 52-year-old male patient who developed critical thrombosis of a mechanical aortic valve prosthesis despite maintaining an adequate and well-controlled anticoagulant regimen. The patient presented with profound hemodynamic instability, markedly reduced ejection fraction, and clinical manifestations consistent with acute decompensated heart failure. On physical and instrumental examination, his condition corresponded to ASA class IV, with a calculated surgical risk of EuroSCORE II=17.28%, indicating an extremely high perioperative mortality risk. Considering both the elevated risk of surgical re-intervention and the rapidly worsening heart failure, the multidisciplinary team decided to initiate systemic thrombolytic therapy as a life-saving alternative. Thrombolysis was performed according to an accelerated protocol using intravenous alteplase at a total dose of 100 mg. Within the first hour of infusion, echocardiography revealed a clear positive trend – restoration of leaflet mobility, a notable reduction in the transprosthetic gradient, and significant improvement in myo­cardial contractility. Subsequent management continued in the intensive care unit with careful hemodynamic and laboratory monitoring. The patient was discharged on the eighth day in a stable condition, free of complications. Follow-up echocardiography two months later confirmed normal and sustained function of the mechanical prosthesis. This case illustrates the high efficacy of systemic thrombolysis as a viable and guideline-supported (ESC/EACTS 2021, Class I, Level B) therapeutic option when surgical treatment is contraindicated or technically impossible.

  • Prognostic value of day-by-day troponin-T dynamics in acute myocardial infarction: a mixed-effects model analysis

    by A.O. Kipot, T.V. Kolesnyk

    Background. . Modeling daily trajectories of high-sensitivity cardiac troponin T (hs-cTnT) in patients during the acute phase of myocardial infarction (MI) may better reflect infarct size and reperfusion success than single-point measurements. However, its association with in-hospital outcomes remains insufficiently explored. Purpose – To evaluate the relationship between daily hs-cTnT trajectories, time-to-peak, and clinical outcomes during the hospital phase in patients with acute MI. Materials and Methods. This single-center study included patients with acute myocardial infarction (AMI, n = 191), in whom high-sensitivity cardiac troponin T (hs-cTnT) levels were measured every 24 hours during hospitalization. Cases without biochemical evidence of myocardial necrosis were not included. The reperfusion strategy for the entire cohort was uniform: early percutaneous coronary intervention performed within 1 hour from hospital admission. Measurements were performed using the Roche Elecsys s100 analyzer (high-sensitivity hs-cTnT assay). Values exceeding the upper measurement limit of the test (26 ng/ml) were treated as the maximal measurable value (26 ng/ml) for statistical analysis. Trajectory analysis was performed using linear mixed-effects models with a random intercept for each patient and fixed effects for «time since individual peak (day 1)», «binary event» (in-hospital death, invasive mechanical ventilation, reduced left-ventricular ejection fraction, reduced cardiac index, multivessel disease), and the interaction «time × event». Separate models were fitted for each clinical event. Secondary analyses included grouping by day of peak (1/2/3/4; subset n = 154) and tertiles of Δhs-cTnT (difference between peak and lowest post-peak value before discharge). All analyses were conducted in R version 4.4.2. Results. . The median age of patients was 64.0 (55.0–71.0) years; most were men (83.2%), and multivessel coronary disease was present in 64.4%. During hospitalization, hs-cTnT concentrations significantly decreased over time (β = −1.24; SE 0.10; t = −12.32; p<0.001). However, the decline was markedly slower in patients who died (time × death interaction: β = +1.23; SE 0.34; t = 3.68; p<0.001). In other events – including invasive mechanical ventilation, reduced ejection fraction, decreased cardiac index, or multivessel disease – the rate of troponin decrease demonstrated patterns that should be confirmed in future studies. The troponin peak most commonly occurred on the 2nd day (59.1%). Patients whose peak occurred on the 1st or 3rd day tended to show a gradual decline in glomerular filtration rate (eGFR), possibly reflecting concomitant impairment of renal perfusion. Analysis by Δhs-cTnT tertiles showed that lower Δhs-cTnT values were associated with longer hospital stays, more advanced stages of cardiogenic shock (according to the SCAI classification), and lower final left-ventricular ejection fraction (p=0.02). Therefore, considering the interaction trends with most clinical events, the pattern of post-peak hs-cTnT dynamics proved decisive. A slower post-peak troponin decline was associated with higher in-hospital mortality, whereas a faster decline was associated with more stable left-ventricular ejection fraction and cardiac index. Conclusions. Among patients with acute myocardial infarction, a slower post-peak decline in hs-cTnT was associated with an increased risk of in-hospital mortality, while a faster decline was associated with more favorable hemodynamic profiles. Time-to-peak and Δhs-cTnT tertiles may serve as potential risk markers and warrant further validation in larger cohort studies.

  • Open Access

    ANALYSIS OF THE OCCURRENCE AND COURSE OF SECONDARY ISCHEMIC MITRAL REGURGITATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

    by L. R. Stetsiuk, I. O. Stetsyuk, A. O. Kipot, V. I. Zaviiskyi

    Introduction. One of the complications due to myocardial infarction is secondary mitral regurgitation, which occur from left atrial or left ventricular (LV) dysfunction or after the rupture of the mitral subvalvular apparatus. Ischemic secondary mitral regurgitation occurs in 7–32% of cases according to various literature sources. Due to its high frequency, it requires more detailed study. The aim – to study the frequency of secondary ischemic mitral regurgitation in patients with acute myocardial infarction based on angiography data and the time before revascularization. Materials and methods. The study included 149 patients with acute myocardial infarction. The following methods were used: general clinical examination, laboratory diagnostics, echocardiography, electrocardiography, and coronary angiography. Results. Among patients with mitral regurgitation, infarct-dependent involvement of the right coronary artery was predominant – 46 (45.54%) patients, p = 0.016, followed by the circumflex branch of the left coronary artery – 34 (33.66%) patients, p = 0.015. A higher percentage of multivessel disease was observed in patients with mitral regurgitation – 57 (56.44%), p = 0.031. Moreover, higher-grade ischemic mitral regurgitation was more frequently observed in patients who underwent revascularization > 12 hours after the onset of symptoms. Conclusions. Secondary ischemic mitral regurgitation in acute myocardial infarction was more commonly diagnosed in patients with infarct caused by right coronary artery lesions, followed by the circumflex branch of the left coronary artery. According to the obtained data, a longer duration from the onset of myocardial infarction symptoms tends to increase the degree of mitral regurgitation. Метою дослідження було вивчення частоти виникнення вторинної ішемічної мітральної регургітації у пацієнтів з гострим інфарктом міокарда відповідно до даних ангіографії та часу до реваскуляризації. У пацієнтів з мітральною регургітацією переважало інфаркт-залежне ураження правої коронарної артерії (ПКА) та огинаючої гілки лівої коронарної артерії (ОГ ЛКА). Виявлено вищий відсоток багатосудинного ураження у пацієнтів з мітральною регургітацією. Ішемічна мітральна регургітація більшого ступеня частіше спостерігалася у пацієнтів, у яких реваскуляризація відбулася більше ніж через 12 годин після початку симптомів. Висновки. Інфаркт-залежне ураження ПКА та ОГ ЛКА частіше зумовлює виникнення вторинної ішемічної мітральної регургітації у хворих із гострим інфарктом. Більш тривалий час з моменту початку симптомів інфаркту міокарда має тенденцію впливати на збільшення ступеня ішемічної мітральної регургітації.